Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
JP Stock MarketDetailed Quotes
2229 CALBEE
- 3257.0
- +5.0+0.15%
20min DelayMarket Closed Dec 11 15:30 JST
436.21BMarket Cap20.46P/E (Static)
3280.0High3236.0Low255.70KVolume3252.0Open3252.0Pre Close832.48MTurnover3637.052wk High0.34%Turnover Ratio133.93MShares2731.552wk Low157.38EPS TTM247.04BFloat Cap5700.0Historical High20.46P/E (Static)75.85MShs Float500.0Historical Low159.22EPS LYR1.35%Amplitude56.00Dividend TTM2.09P/B100Lot Size1.72%Div YieldTTM
CALBEE Key Stats
Quarterly+Annual
YOY
| (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.15%77.66B | 8.49%303.03B | 6.88%75.69B | 6.62%80.27B | 8.88%73.92B | 11.99%73.16B | 13.81%279.32B | 18.13%70.82B | 15.77%75.29B | 12.13%67.89B |
| Cost of revenue | 3.82%50.61B | 6.32%201.07B | 4.66%51.35B | 2.81%51.01B | 8.05%49.96B | 10.29%48.75B | 17.12%189.12B | 20.27%49.07B | 17.24%49.61B | 16.58%46.24B |
| Gross profit | 10.82%27.05B | 13.04%101.96B | 11.89%24.34B | 13.97%29.26B | 10.64%23.95B | 15.54%24.41B | 7.44%90.2B | 13.56%21.75B | 13.04%25.67B | 3.68%21.65B |
| Operating expense | 12.87%19.37B | 9.84%74.65B | 18.01%20.75B | 6.73%19.06B | 5.48%17.68B | 8.89%17.16B | 15.55%67.97B | 17.98%17.58B | 18.03%17.86B | 15.48%16.77B |
| Operating profit | 5.95%7.68B | 22.81%27.31B | -13.91%3.59B | 30.51%10.2B | 28.38%6.27B | 35.07%7.24B | -11.55%22.23B | -1.91%4.17B | 3.07%7.82B | -23.24%4.88B |
| Net non-operating interest income (expenses) | -16.00%21M | 986.36%195M | 1,220.00%66M | 460.00%54M | 516.67%50M | 25M | -46.67%-22M | 5M | -7.14%-15M | -500.00%-12M |
| Non-operating interest income | 47.95%108M | 217.86%445M | 209.62%161M | 226.47%111M | 257.14%100M | 180.77%73M | 66.67%140M | 136.36%52M | 100.00%34M | 21.74%28M |
| Non-operating interest expense | 81.25%87M | 54.32%250M | 102.13%95M | 16.33%57M | 25.00%50M | 84.62%48M | 63.64%162M | 113.64%47M | 58.06%49M | 60.00%40M |
| Net investment income | -29.04%1.46B | 205.15%3.55B | 833.55%1.42B | 43.01%-803M | 4.86%884M | 30.04%2.05B | -33.52%1.16B | -85.73%152M | -406.97%-1.41B | 401.79%843M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 25M | 38.89%75M | 0 | 0 | 871.43%54M | 700.00%54M | 0 | |||
| Income from associates and other participating interests | -64.86%13M | -29.17%17M | -148.00%-12M | -144.44%-44M | 157.14%36M | 1,133.33%37M | 26.32%24M | 212.50%25M | -18M | 250.00%14M |
| Special income (charges) | 38.10%-39M | -18.72%-1.17B | -7.70%-867M | -51.64%-185M | -2,033.33%-58M | 1.56%-63M | -249.12%-988M | -126.76%-805M | -154.71%-122M | 103.70%3M |
| Less:Impairment of capital assets | -40.00%12M | 30.36%146M | -55.26%17M | 113.64%47M | 129.63%62M | -20.00%20M | 13.13%112M | 52.00%38M | -12.00%22M | 12.50%27M |
| Less:Other special charges | -37.21%27M | 94.61%650M | 110.22%473M | 38.00%138M | 86.67%-4M | 10.26%43M | 81.52%334M | -38.19%225M | 140.32%100M | -152.63%-30M |
| Less:Write off | ---- | -30.44%377M | ---- | ---- | ---- | ---- | --542M | ---- | ---- | ---- |
| Other non-operating income (expenses) | 63.55%175M | 34.68%233M | -7.06%79M | 2,000.00%38M | -83.93%9M | 214.71%107M | 18.49%173M | 21.43%85M | -105.26%-2M | 143.48%56M |
| Income before tax | -0.80%9.33B | 33.40%30.2B | 15.83%4.27B | 48.22%9.26B | 25.60%7.27B | 35.93%9.4B | -15.35%22.64B | -26.67%3.69B | -24.79%6.25B | -9.77%5.79B |
| Income tax | -37.46%1.86B | 27.02%9.74B | 2.24%1.51B | 36.94%2.82B | 28.28%2.43B | 33.17%2.98B | -9.48%7.67B | -7.87%1.48B | -25.23%2.06B | -13.27%1.9B |
| Net income | 16.21%7.46B | 36.68%20.47B | 24.92%2.77B | 53.74%6.44B | 24.33%4.84B | 37.25%6.42B | -18.08%14.97B | -35.42%2.22B | -24.59%4.19B | -7.99%3.89B |
| Net income continuous operations | 16.21%7.46B | 36.67%20.47B | 24.88%2.77B | 53.76%6.44B | 24.30%4.84B | 37.25%6.42B | -18.08%14.97B | -35.44%2.22B | -24.57%4.19B | -7.97%3.89B |
| Noncontrolling interests | 131.36%391M | 188.06%579M | 276.92%46M | 528.13%137M | 69.40%227M | 35.20%169M | -10.27%201M | -132.91%-26M | -214.29%-32M | 2,580.00%134M |
| Net income attributable to the company | 13.10%7.07B | 34.62%19.89B | 21.42%2.72B | 49.31%6.3B | 22.72%4.61B | 37.32%6.25B | -18.17%14.77B | -33.14%2.24B | -23.59%4.22B | -11.05%3.76B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 13.10%7.07B | 34.62%19.89B | 21.42%2.72B | 49.31%6.3B | 22.72%4.61B | 37.32%6.25B | -18.17%14.77B | -33.14%2.24B | -23.59%4.22B | -11.05%3.76B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 13.15%56.63 | 38.26%159.22 | 21.26%21.79 | 53.75%50.46 | 26.83%36.92 | 41.95%50.05 | -15.48%115.16 | -30.94%17.97 | -21.01%32.82 | -7.91%29.11 |
| Diluted earnings per share | 13.15%56.63 | 38.26%159.22 | 21.46%21.789 | 53.74%50.4567 | 26.85%36.9183 | 41.95%50.05 | -15.48%115.16 | -30.90%17.9388 | -21.01%32.82 | -7.93%29.1044 |
| Dividend per share | 0 | 7.69%56 | 7.69%56 | 0 | 0 | 0 | 0.00%52 | 0.00%52 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |